Systematic Review of Cardiovascular Manifestations in COVID-19 and Management Consideration

Fernanda Savitri Mega Pratistha; Rani Paramitha Iswari Maliawan; Hendy Wirawan; I.G.N. Putra Gunadhi

doi:10.3889/oamjms.2022.9431

Authors

Fernanda Savitri Mega Pratistha Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia
Rani Paramitha Iswari Maliawan Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital Denpasar, Denpasar, Indonesia
Hendy Wirawan Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital Denpasar, Denpasar, Indonesia
I.G.N. Putra Gunadhi Departement of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital Denpasar, Denpasar, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2022.9431

Keywords:

COVID-19, Cardiovascular, Manifestation, Management, Systematic review

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) is a health problem that is still engulfing the world that contributes to the high mortality rate globally. Death arises from the severity of the disease due to complications in important organs such as the heart. The purpose of this study was to systematically review the manifestations of cardiovascular disease in COVID-19 patients and their management in terms of published articles.

Method: This research is a systematic review research. The research was conducted using the PRISMA method. Article searches are carried out by online publications throughPubMed, Science Direct and Google Scholarthat meet the inclusion and exclusion criteria. The population is articles about the manifestations of cardiovascular disease in COVID-19 patients and their management between 2011 and 2021. Inclusion criteria are studies that examine the manifestations of cardiovascular disease in COVID-19 patients and their management using primary data in the form of cohort research designs, in English and full text available. The exclusion criteria were a case study, review study and used secondary data. The data were analyzed by univariate analysis by calculating the frequency and percentage.

Result: The results show that several manifestations of cardiovascular disease in COVID-19 patients include cardiac injury, heart failure, myocardial infarction, myocarditis, cardiomegaly and others.Complications of these diseases occur with or without comorbidities and the risk increases with comorbid cardiovascular disease. The management of COVID-19 patients is basically done with antiviral agents, reducing symptoms and protecting important organs such as the heart.

Conclusion: In the treatment of COVID-19 patients with cardiovascular complications, the use of antiviral agents such as lopinavir or ritonavir should be used with caution because: may interact with cardiovascular drugs. Mechanical circulation support is suggested and the use of extracorporeal membrane oxygenation (ECMO) can also be performed totreat cardiovascular complications in COVID-19 patients.

Keywords: COVID-19, cardiovascular, manifestation, management, systematic review.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol. 2020;76(5):533-46. PMid:32517963 DOI: https://doi.org/10.1101/2020.04.20.20072702

World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Geneva: World Health Organization; 2021.

Wadhera RK, Shen C, Gondi S, Chen S, Kazi DS, Yeh RW, et al. Cardiovascular deaths during the COVID-19 pandemic in the United States. J Am Colledge Cardiol. 2021;77(2):159-69. DOI: https://doi.org/10.1016/j.jacc.2020.10.055

Lee CC, Ali K, Connell D, Mordi IR, George J, Lang EM, et al. COVID-19-associated cardiovascular complications. Diseases. 2021;9(3):47. PMid:34209705 DOI: https://doi.org/10.3390/diseases9030047

Deng Q, Hu B, Zhang Y. Since January 2020 Elsevier has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID-19. The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company’s Public News and Information. Netherlands: Elsevier; 2020.

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-5. https://doi.org/10.1016/j.ijid.2020.03.017 PMid:32173574 DOI: https://doi.org/10.1016/j.ijid.2020.03.017

Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ, et al. Presymptomatic transmission of SARS-CoV-2-Singapore. Morb Mortal Wkly Rep. 2020;69(14):411-5. https://doi.org/10.15585/mmwr.mm6914e1 PMid:32271722 DOI: https://doi.org/10.15585/mmwr.mm6914e1

Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X. Analysis of 92 deceased patients with COVID-19. J Med Virol. 2020;92(11):2511-15. https://doi.org/10.1002/jmv.25891 PMid:32293741 DOI: https://doi.org/10.1002/jmv.25891

Hong KS, Lee KH, Chung JH, Shin KC, Choi EY, Jin HJ, et al. Clinical features and outcomes of 98 patients hospitalized with sars-cov-2 infection in daegu, south korea: A brief descriptive study. Yonsei Med J. 2020;61(5):431-7. https://doi.org/10.3349/ymj.2020.61.5.431 PMid:32390367 DOI: https://doi.org/10.3349/ymj.2020.61.5.431

Zeng JH, Liu YX, Yuan J, Wang FX, Wu WB, Li JX, et al. First case of COVID-19 complicated with fulminant myocarditis: A case report and insights. Infection. 2020;48(5):773-7. https://doi.org/10.1007/s15010-020-01424-5 PMid:32277408 DOI: https://doi.org/10.1007/s15010-020-01424-5

Peretto G, Villatore A, Rizzo S, Esposito A, De Luca G, Palmisano A, et al. The spectrum of COVID-19-associated myocarditis: A patient-tailored multidisciplinary approach. J Clin Med. 2021;10(9):1974. PMid:34064463 DOI: https://doi.org/10.3390/jcm10091974

Prabhakaran D, Perel P, Roy A, Singh K, Raspail L, Faria-Neto JR, et al. Erratum: Management of cardiovascular disease patients with confirmed or suspected covid-19 in limited resource settings. Glob Heart. 2020;15(1):44. https://doi.org/10.5334/gh.823 PMid:32923338 DOI: https://doi.org/10.5334/gh.823

Chen T, Wu D, Chen H. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ. 2020;368:m1295. https://doi.org/10.1136/bmj.m1295 DOI: https://doi.org/10.1136/bmj.m1295

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802-10. https://doi.org/10.1001/jamacardio.2020.0950 PMid:32211816 DOI: https://doi.org/10.1001/jamacardio.2020.0950

Zhou F. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: A retrospective cohort study. J Med Study Res. 2020;3:1-2. DOI: https://doi.org/10.24966/MSR-5657/100015

Yu Y, Xu D, Fu S, Zhang J, Yang X, Xu L, et al. Patients with COVID-19 in 19 ICUs in Wuhan, China: A cross-sectional study. Crit Care. 2020;24:1-10. PMid:32410714 DOI: https://doi.org/10.1186/s13054-020-02939-x

Yang H, Sun G, Tang F, Peng M, Gao Y, Peng J, et al. Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019. J Infect. 2020;81:e40-4. https://doi.org/10.1016/j.jinf.2020.04.003 PMid:32294503 DOI: https://doi.org/10.1016/j.jinf.2020.04.003

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-8. https://doi.org/10.1001/jamacardio.2020.1017 PMid:32219356 DOI: https://doi.org/10.1001/jamacardio.2020.1017

Shi S, Qin M, Cai Y, Liu T, Shen B, Yang F, et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J. 2020;41:2070-9. https://doi.org/10.1093/eurheartj/ehaa408 DOI: https://doi.org/10.1093/eurheartj/ehaa408

Daniels CJ, Rajpal S, Greenshields JT, Rosenthal GL, Chung EH, Terrin M, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: Results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021;6:1078-87. https://doi.org/10.3410/f.740190589.793586024 PMid:34042947 DOI: https://doi.org/10.3410/f.740190589.793586024

Kim M, Nam JH, Son JW, Kim SO, Son NH, Ahn CM, et al. Cardiac manifestations of coronavirus disease 2019 (COVID-19): A multicenter cohort study. J Korean Med Sci. 2020;35(40):e366. PMid:33075857 DOI: https://doi.org/10.3346/jkms.2020.35.e366

Myhre PL, Heck SL, Skranes JB, Prebensen C, Jonassen CM, Berge T, et al. Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity. Am Heart J. 2021;242:61-70. https://doi.org/10.1016/j.ahj.2021.08.001 PMid:34400140 DOI: https://doi.org/10.1016/j.ahj.2021.08.001

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. PMid:31986264 DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

Daniels LB, Ren J, Kumar K, Bui QM, Zhang J, Zhang X, et al. Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American heart association’s COVID-19 cardiovascular disease registry. PLoS One. 2021;16(7):1-16. https://doi.org/10.1371/journal.pone.0254635 PMid:34264974 DOI: https://doi.org/10.1371/journal.pone.0254635

Fried JA, Ramasubbu K, Bhatt R, Topkara VK, Clerkin KJ, Horn E, et al. The variety of cardiovascular presentations of COVID-19. Circulation. 2020;141(23):1930-6. PMid:32243205 DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.047164

Saus PS, Hanafy D, Barack R. COVID 19 with cardiac injury complication, a case report. Indones J Cardiol. 2020;41:49-53. https://doi.org/10.30701/ijc.1011 DOI: https://doi.org/10.30701/ijc.1011

Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patientswith COVID-19 inWashington state. JAMA. 2020;323(16):755-60. https://doi.org/10.1001/jama.2020.4326 PMid:32191259 DOI: https://doi.org/10.1001/jama.2020.4326

Liu ZM, Li JP, Wang SP, Chen DY, Zeng W, Chen SC, et al. Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19. Int J Med Sci. 2020;17(16):2468-76. https://doi.org/10.7150/ijms.48396 PMid:33029089 DOI: https://doi.org/10.7150/ijms.48396

Arévalos V, Ortega-Paz L, Fernandez-Rodríguez D, Jiménez- Díaz VA, Rius JB, Campo G, et al. Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol. PLoS One. 2021;16(7):1-9. https://doi.org/10.1371/journal.pone.0255263 PMid:34324524 DOI: https://doi.org/10.1371/journal.pone.0255263

Basu-Ray I, Almaddah NK, Adeboye A, Soos MP. Cardiac manifestations of coronavirus (COVID-19). In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2022.

Guan W, Liang W, Zhao Y, Liang HR, Chen ZH, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Eur Respir J. 2020;55:640. PMid:32217650 DOI: https://doi.org/10.1183/13993003.01227-2020

Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:819-24. https://doi.org/10.1001/jamacardio.2020.1096 PMid:32219357 DOI: https://doi.org/10.1001/jamacardio.2020.1096

Caforio AL, Mancini D, Dardas TF. COVID-19: Evaluation and Management of Cardiac Disease in Adults. Availabel from: https://www.uptodate.com/contents/covid-19-evaluation-and-management-of-cardiac-disease-in-adults [Last accessed on 16 Jan 2022]

Chow J, Alhussaini A, Calvillo-Argüelles O, Billia F, Luk A. Cardiovascular collapse in COVID-19 infection: The role of venoarterial extracorporeal membrane oxygenation (VA-ECMO). CJC Open. 2020;2(4):273-7. https://doi.org/10.1016/j.cjco.2020.04.003 PMid:32363334 DOI: https://doi.org/10.1016/j.cjco.2020.04.003

Burhan E, Susanto AD, Nasution SA. Protokol Tatalaksana Covid-19. Indonesia: Kementeri Kesehat Republik Indones; 2021.